Cutting-Edge Cannabis Cultivar Trials in Victoria

Australian medicinal cannabis cultivators and brands are set to benefit from the introduction of cutting-edge genetics as trials for the first batch of new cultivars from Apollo Green, a Canadian-based genetics leader and wholly owned subsidiary of Biortica Agrimed, have commenced at the Victorian Green Farmers facility. Among the cultivars entering early flower is the highly anticipated OG Triploid, developed by California’s renowned Humboldt Seed Company, known for their exceptional contributions to cannabis genetics globally. 

The introduction of these advanced genetics, including the revolutionary triploids, marks a significant milestone for the Australian medicinal cannabis landscape. Triploids, naturally bred plants with three sets of chromosomes, deliver enhanced yield potential, increased trichome density, and improved uniformity, making them highly sought after by cultivators. Unlike traditional diploids, triploids focus their energy on growth and resin production due to their sterility, offering cultivators a consistent, high-performing option for medicinal flower and extraction applications. 

 “Triploid genetics represent a new frontier in cultivation,” said Tom Varga, CEO of Biortica Agrimed. “By offering enhanced consistency and improved production potential, we’re helping Australian growers raise the bar in terms of quality and reliability. The most recent delivery of breeders cuts from Apollo Green means we have the exact strain that has gained success in the North American market, and we know exactly how it will perform here. That is very exciting and there are other genetics in this trial as well that are equally as impressive.” 

Ben Ellerton, Chief Horticultural Officer at Biortica Agrimed, expressed optimism about the coming results: “These cultivars, particularly the triploids, are already showing remarkable consistency and vigour in early stages. As we move through the full growth cycle, I’m excited to see how they develop. Their potential to provide more uniform crops and improved outcomes for growers—and ultimately patients—is truly promising.” 

Apollo Green has played a key role in making these groundbreaking genetics accessible to the Australian market. With one of the largest cannabis genetics libraries in the world, Apollo Green has facilitated the transfer of high-performing cultivars like OG Triploid and other Humboldt classics into the hands of Australian growers. 

The Green Farmers facility trials highlight the growing potential of the Australian medicinal cannabis industry to adopt world-class genetics. Industry observers note that such collaborations signal a brighter future for local cultivation, providing growers with the tools needed to improve efficiency, productivity, and quality. 

The trials come at a time when the Australian medicinal cannabis industry is rapidly evolving, with cultivators seeking ways to deliver better outcomes for patients while advancing the standards of the industry. These new genetics represent an important step in achieving that goal.